Comparison of the ImmunoCyt test and urinary cytology with other urine tests in the detection and surveillance of bladder cancer

World Journal of Urology

Volumn 22, Issue 2, 2004, Pages 145-149

  Toma, Marieta I ^a   Friedrich, Martin G ^a   Hautmann, Stefan H ^a   Jäkel, K Thorsten ^a   Erbersdobler, Andreas ^a   Hellstern, Angelika ^a   Huland, Hartwig ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Cytology; FISH; ImmunoCyt; Urine markers

Indexed keywords

ARTICLE; BLADDER TUMOR; CANCER STAGING; COMPARATIVE STUDY; CYTOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; FOLLOW UP; HUMAN; PATHOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; URINE; VALIDATION STUDY;

FLUORESCENT ANTIBODY TECHNIQUE; FOLLOW-UP STUDIES; HUMANS; NEOPLASM STAGING; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; URINARY BLADDER NEOPLASMS; URINE;

EID: 8344283132     PISSN: 07244983     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00345-003-0390-8     Document Type: Article

References (22)

1. Badalament RA, Fair WR, Whitmore WFJr, Melamed MR (1988) The relative value of cytometry and cytology in the management of bladder cancer: the Memorial Sloan-Kettering Cancer Center experience. Semin Urol 6:22-30
2. Leyh H, Marberger M, Conort P, Sternberg C, Pansadoro V, Pagano F, Bassi P, Boccon-Gibod L, Ravery V, Treiber U, Ishak L (1999) Comparison of the BTA stat test with voided urine cytology and bladder wash cytology in the diagnosis and monitoring of bladder cancer. Eur Urol 35:52-56
3. Chautard D, Daver A, Bocquillon V, Verriele V, Colls P, Bertrand G, Soret JY (2000) Comparison of the BTA TRAK test with voided urine cytology in the diagnosis and follow up of bladder tumors. Eur Urol 38:686-690
4. Ellis WJ, Blumenstein BA, Ishak LM, Enfield DL (1997) Clinical evaluation if the BTA TRAK assay and comparison to voided urine cytology and the Bard BTA test in patients with recurrent bladder tumors. The Multi Center Study Group. Urology 50:882-887
5. Pode D, Shapiro A, Wald M, Nativ O, Laufer M, Kaver I (1999) Noninvasive detection of bladder cancer with the BTA stat test. J Urol 161:443-446
6. Casella R, Huber P, Blochlinger A, Stoffel F, Dalquen P, Gasser TC, Lehmann K (2000) Urinary level of nuclear matrix protein 22 in the diagnosis of bladder cancer: experience with 130 patients with biopsy confirmed tumor. J Urol 164:1926-1928
7. Landman J, Chang Y, Kavaler E, Droller MJ, Liu BC (1998) Sensitivity and specificity of NMP22, telomerase, and BTA in the detection of human bladder cancer. Urology 52:398-302
8. Topsakal M, Karadeniz T, Anac M, Donmezer S, Besisik A (2001) Assessment of Fibrin-Fibrinogen Degradation Products (Accu Dx) test in bladder cancer patients. Eur Urol 39:287-289
9. Heicappell R, Schostak M, Mueller M, Miller K (2000) Evaluation of urinary bladder cancer antigen as a marker for diagnosis of transitional cell carcinoma of the bladder. Scand J Clin Lab Invest 60:275-282
10. Sanchez-Carbayo M, Herrero E, Megias J, Mira A, Espasa A, Chinchilla V, Soria F (1999) Initial evaluation of the diagnostic performance of the new urinary bladder cancer antigen test as a tumor marker for transitional cell carcinoma of the bladder. J Urol 161:1110-1115
11. Halling KC, King W, Sokolova IA, Meyer RG, Burkhardt HM, Halling AC, Cheville JC, Sebo TJ, Ramakumar S, Stewart CS, Pankratz S, O'Kane DJ, Seelig SA, Lieber MM, Jenkins RB (2000) A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. J Urol 164:1768-1775
12. Jung I, Reeder JE, Cox C, Siddiqui JF, Oconnel MJ, Yang Z, Messing EM, Wheeless LL (1999) Chromosome 9 monosomy by fluorescence in situ hybridization of bladder irrigation specimens is a predictive of tumor recurrence. J Urol 162:1900-1903
13. Pycha A, Mian C, Posch B, Haitel A, El Baz M, Ghoneim MA, Marberger M (1998) Numerical aberrations of chromosomes 7, 9 and 17 in squamous cell and transitional cell cancer of the bladder: a comparative study performed by fluorescence in situ hybridization. J Urol 160:737-740
14. Klan R, Huland E, Baisch H, Huland H (1991) Sensitivity of urinary quantitative immunocytology with monoclonal antibody 486p3/12 in 241 unselected patients with bladder carcinoma. J Urol 145:495-497
15. Mian C, Pycha A, Wiener H, Haitel A, Lodde M, Marberger M (1999) ImmunoCyt: a new tool for detecting transitional cell cancer of the urinary tract. J Urol 161:1486-1489
16. Olsson H, Zackrisson B (2001) ImmunoCyt™ a useful method in the follow-up protocol for patients with urinary bladder carcinoma. Scand J Urol Nephrol 35:280-282
17. Vriesema JLJ, Atsma F, Kiemeney ALM, Peelen WP, Witjes JA, Schalken JA (2001) Diagnostic efficacy of the ImmunoCyt test to detect superficial bladder cancer recurrence. Urology 58:367-371
18. Fradet Y, Lockhart C (1997) Performance characteristics of a new monoclonal antibody test for bladder cancer: ImmunoCyt. Can J Urol 4:400
19. Boman H, Hedelin H, Holmang S (2002) Four bladder tumor markers have a disappointingly low sensitivity for small size and low grade recurrence. J Urol 167:80-83
20. Lokeshwar VB, Soloway MS (2001) Current bladder tumor tests: does their projected utility fulfil clinical necessity? J Urol 165:1067-1977
21. Friedrich MG, Hellstern A, Toma, MI, Hammerer P, Huland H (2003) Are false positive urine tests in the diagnosis of bladder cancer really wrong - or do they predict tumour recurrence? Eur Urol 43:146-151
22. Pode D, Golijanin D, Sherman Y, Lebensart P, Shapiro A (1998) Immunostaining of Lewis X in cells from voided urine, cytopathology and ultrasound for noninvasive detection of bladder tumors. J Urol 159:389-392